You are here: Home: Meet The Professors - Lung Cancer 1 | 2008: Faculty Affliations and Disclosures

Content Validation and Disclosures

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Kim — Advisory Committee: AstraZeneca Pharmaceuticals LP, ImClone Systems Incorporated; Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, ImClone Systems Incorporated, OSI Oncology, Sanofi-Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr Lilenbaum — Consulting Agreement: Genentech BioOncology. Dr Socinski — Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, Pfizer Inc, Sanofi-Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis.

COMMUNITY PANEL — Drs Hoffman and Levy had no real or apparent conflicts of interest to disclose. Dr Farber — Advisory Committee: Biogen Idec, Genentech BioOncology. Dr Henderson — Consulting Agreements: Abraxis BioScience, Bayer Pharmaceuticals Corporation, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, ImClone Systems Incorporated, Millennium Pharmaceuticals Inc, Onyx Pharmaceuticals Inc, Pfizer Inc, Sanofi-Aventis, Wyeth; Speakers Bureau: Abraxis BioScience, Amgen Inc, Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb Company, Genentech BioOncology, ImClone Systems Incorporated, Onyx Pharmaceuticals Inc, Pfizer Inc, Sanofi-Aventis. Dr Hussein — Advisory Committee: Bayer Pharmaceuticals Corporation, Roche Laboratories Inc; Speakers Bureau: Amgen Inc, Novartis Pharmaceuticals Corporation, Sanofi-Aventis. Dr Kanner — Advisory Committee: AstraZeneca Pharmaceuticals LP, Celgene Corporation, Eisai Inc, Millennium Pharmaceuticals Inc. Dr Safa — Paid Research: MedImmune Inc, Sanofi-Aventis; Speakers Bureau: Genentech BioOncology, Pfizer Inc.

MODERATOR — Dr Love does not receive any direct remuneration from industry. Research To Practice receives funds in the form of educational grants to develop CME activities from the following commercial interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company, Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Medical Oncologist Community Panel

Charles M Farber, MD, PhD Chief, Section of Hematology Oncology Department of Medicine Morristown Memorial Hospital Carol G Simon Cancer Center Morristown, New Jersey Charles A Henderson, MD Director of Clinical Research Peachtree Hematology Oncology Consultants Atlanta, Georgia

Kenneth R Hoffman, MD, MPH Teaneck, New Jersey Atif M Hussein, MD Medical Director Memorial Cancer Institute Hollywood, Florida Steven P Kanner, MD Oncology Associates of South Florida Hollywood, Florida

Isaac Levy, MD Memorial Hospital West Pembroke Pines, Florida Malek Safa, MD Medical Oncology Hematology Association Dayton, Ohio